Michael Greiner - 03 Dec 2024 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
Interim CEO
Signature
/s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
Issuer symbol
AVNS
Transactions as of
03 Dec 2024
Net transactions value
$0
Form type
4
Filing time
05 Dec 2024, 10:37:22 UTC
Previous filing
31 Oct 2024
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Award $0 +10,000 +5.2% $0.000000 200,898 03 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest on December 3, 2025, provided that if the Reporting Person's employment is terminated without cause prior to such date, all the TRSUs will vest immediately. Each TRSU is the economic equivalent of one share of Common Stock.